AtriCure, Inc.
ATRC
$28.89
$0.100.35%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 14.26% | 13.05% | 15.84% | 17.09% | 13.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.26% | 13.05% | 15.84% | 17.09% | 13.57% |
| Cost of Revenue | 3.05% | 11.07% | 13.12% | 17.78% | 12.36% |
| Gross Profit | 18.01% | 13.73% | 16.75% | 16.86% | 13.98% |
| SG&A Expenses | 11.17% | 8.53% | 6.82% | 6.51% | 5.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.60% | -0.57% | 8.71% | 15.31% | 8.19% |
| Operating Income | 108.83% | 117.15% | 102.81% | 13.62% | 45.46% |
| Income Before Tax | 106.05% | 115.42% | 98.86% | 23.55% | 50.27% |
| Income Tax Expenses | 19.67% | 127.07% | -43.79% | 3.16% | 30.60% |
| Earnings from Continuing Operations | 101.60% | 111.28% | 96.60% | 22.70% | 49.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 101.60% | 111.28% | 96.60% | 22.70% | 49.15% |
| EBIT | 108.83% | 117.15% | 102.81% | 13.62% | 45.46% |
| EBITDA | 766.55% | 178.35% | 317.08% | 61.34% | 86.54% |
| EPS Basic | 101.54% | 111.08% | 96.64% | 24.02% | 49.86% |
| Normalized Basic EPS | 105.94% | 115.18% | 98.90% | 24.78% | 45.28% |
| EPS Diluted | 101.54% | 110.87% | 96.64% | 24.02% | 49.86% |
| Normalized Diluted EPS | 105.83% | 114.88% | 98.90% | 24.78% | 45.28% |
| Average Basic Shares Outstanding | 1.99% | 1.77% | 1.73% | 1.73% | 1.44% |
| Average Diluted Shares Outstanding | 3.49% | 3.71% | 1.73% | 1.73% | 1.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |